Skip to main content
Laser Therapy logoLink to Laser Therapy
. 2012 Mar 28;21(1):39–42. doi: 10.5978/islsm.12-CR-01

Co2 Laser Treatment of Drug-Induced Gingival Overgrowth - Case Report -

Carlo Fornaini 1,2,, Jean Paul Rocca 1,2
PMCID: PMC3944592  PMID: 24610979

Introduction

Possibility, by several drugs, to produce, as collateral effect, gingival overgrowth, is largely described in literature 1,2) since 1939, when Kimball, reported for the first time the case of a hyperplasic modification in the gum of an epileptic patient treated with Dilantin. Actually, the agents causing gingival hyperplasia belong to three categories: anticonvulsivants (Phenytoin), immunosuppressant (Cyclosporine A) and calcium channel blockers for cardiovascular disease. 3)

The last belongs to the so called “calcium channel blockers” and its main action is to stop the passage of Ca++ ions through the membranes of the muscular cells of vessels and heart without modifying the haematic level of the calcium; in this way the contractile processes of the main arteries and coro-naries are inhibited. 46)

Gingival overgrowth normally appears within 13 months after the start of therapy, beginning from the interdental papilla; 7) clinical manifestation usually is similar with different type of drugs, even if some authors reported a more lobulated and hyperaemic gingival for patients treated with Cyclosporin A. 8)

Histopathologic characteristics of gingival lesions are very similar independently from the drug assumed, and they consist in an excessive accumulation of extracellular matrix proteins (e.g. collagen) or amorphous ground substance, with a connective tissue response more implicated than epithelial cell layer involvement; 9) it is also always present a lym-pho-plasmocitary infiltrate, typical of chronic inflammation even when an acute flogosis, due to the bacterial plaque in the sulcular areas, is associated. 10,11) In these conditions, when the anamnestic investigation leads to the hypothesis of a relation between the agent assumed and the conditions of gums, it is mandatory to contact the specialist who prescribed the agent in order to substitute this drug with another, if possible.

The surgical therapy is not easy, due to the particular general clinical situation of these patients: 12) even if, in most important cases conventional intervention by scalpel must be done during hospitaliza-tion in order to have a control of bleeding because, in this kind of patient, risk is very high, 13,14) several authors proposed also the use of laser surgery in alternative to conventional intervention: less bleeding and pain, easier post-operative period, much less wound contraction and scarring are the advantages of this technique vs. scalpel. 15)

Use of several different wavelengths to treat gingival overgrowth, such Argon, Nd:YAG, Diode, Er,Cr:YSGG, Er:YAG and CO2 has been reported in several works, 1618) but in the case below described we decided to use Carbon Dioxide Laser, considering the importance of the lesion, the age of the patient and his general health conditions. 19)

CO2 is a gas active medium laser which emits a beam of 10600 nm, in region of far infrared spectrum, with a great affinity for water and, even if it generally has a delivery system by articulated arm, it can also be distributed by hollow fibbers; the great advantage of this laser is that it can emit in C^W (Continuous Wave), in Pulsed Mode and also in Superpulsed Mode and this last way allows to control thermal elevation in target tissue. In this case we decided to utilise it in two modalities, superpulsed to make ablation and CW to produce coagulation in the tissue.

Clinical Case

Patient DL, 75 years old male, came to the hospital for a great inflammation of gum and, at clinical observation, it was appreciated a situation of gingival overgrowth with oedema and bleeding of the gum, associated to poor oral hygiene conditions. The patient told he had a great discomfort related to eating.

Clinical history of the patient revealed he was in treatment by several years with Nifepidine to control his chronic hypertension and his medical doctor was soon contacted in order to take in consideration to change the drug; according with patient, a laserassisted surgical intervention was chosen to reduce the hypertrophy of the gum.

Considering the age of the patient, his general conditions and the state of great inflammation and bleeding of the gums, we decided to use CO2 laser, in order to have a great coagulation of the wound; before intervention patient was treated by dental hygienist and instructed to maintain an adequate oral hygiene.

The intervention was made in three sessions, with an interval of one week between every session and the laser appliance used was Miran 25 Mediclase (Israel).

Before every session anaesthesia of the area of intervention was obtained by injection of a phial of carbocaine; then, a first passage to make ablation of the hypertrophic tissue was applied in Superpulsed Mode (10 W, 250 Hz, 300 psec pulse duration), followed by a second passage performed in CW (4 W) to make coagulation in order to reduce bleeding and avoid use of suture.

A sample of the excised gum was sent to pathologist in order to make histological examination: diagnosis of gingival hypertrophia was confirmed also from a histological point of view.

After intervention no drugs were prescribed to patient and evaluation of pain, made by a form filled by the patient, showed the absence of any significant postoperative problem; the complete healing process was observed after three weeks and the observations made monthly did not show any relapse, even if the very poor hygienic conditions of the patient.

We may conclude that the use of CO2 superpulsed laser is a great opportunity to treat important pathological situations of gum, even in patients with general health problems with success and comfort of patients.

Fig. 1:

Fig. 1:

Patient before oral care

Fig. 2:

Fig. 2:

After first surgical session

Fig. 3:

Fig. 3:

Samples to pathological examination

Fig. 4:

Fig. 4:

Patient before the second surgical session

Fig. 5:

Fig. 5:

Patient after second surgical session

Fig. 6:

Fig. 6:

Patient after third surgical session

Fig. 7:

Fig. 7:

Patient one month after last intervention

Fig. 8:

Fig. 8:

Patient one year after intervention

References

  • 1:Kataoka M, Kido J, Shinohara Y, Nagata T.: Druginduced gingival overgrowth--a review. Biol Pharm Bull. 2005. October;28(10):1817-21 [DOI] [PubMed] [Google Scholar]
  • 2:Tajani AH, Nesbitt SD.: Gingival hyperplasia in a patient with hypertension. J Clin Hypertens (Greenwich). 2008. November;10(11):863-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3:Thompson AL, Herman WW, Konzelman J, Collins MA.: Treating patients with drug-induced gingival overgrowth. J Dent Hyg. 2004. Fall;78(4):12 Epub 2004. October 1 [PubMed] [Google Scholar]
  • 4:Fourtounas C, Vlachojannis JG. : Gingival hyperplasia and calcium channel blockers. J Clin Hypertens (Greenwich). 2009. February;11(2):111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5:Meisel P, Schwahn C, John U, Kroemer HK, Kocher T.: Calcium antagonists and deep gingival pockets in the population-based SHIP study. Br J Clin Pharmacol. 2005. November;60(5):552–-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6:Palattella A, Marano G, Bollero P, Tomarelli F.: Gingival overgrowth with calcium-channel blockers. Treatment options. Minerva Stomatol. 2005. June;54(6):339-49 [PubMed] [Google Scholar]
  • 7:Bullon P, Gallardo I, Goteri G, Rubini C, Battino M, Ribas J, Newman HN.: Nifedipine and cyclosporin affect fibroblast calcium and gingiva. J Dent Res. 2007. April;86(4):357-62 [DOI] [PubMed] [Google Scholar]
  • 8:Gonçalves SC, Díaz-Serrano KV, de Queiroz AM, Palioto DB, Faria G.: Gingival overgrowth in a renal transplant recipient using cyclosporine A. J Dent Child (Chic). 2008. September-December;75(3):313-7 [PubMed] [Google Scholar]
  • 9:Lafzi A, Farahani RM, Shoja MA. : Phenobarbitalinduced gingival hyperplasia. J Contemp Dent Pract. 2007. September 1;8(6):50-6 [PubMed] [Google Scholar]
  • 10:Wynn RL. : Calcium channel blockers and gingival hyperplasia--an update. Gen Dent. 2009. March–April;57(2): 105-7 [PubMed] [Google Scholar]
  • 11:Lucchesi JA, Cortelli SC, Rodrigues JA, Duarte PM.: Severe phenytoin-induced gingival enlargement associated with periodontitis. Gen Dent. 2008. March–April;56(2):199. [PubMed] [Google Scholar]
  • 12:de Carvalho Farias B, Cabral PA, Gusmão ES, Jamelli SR, Cimões R.: Non-surgical treatment of gingival overgrowth induced by nifedipine: a case report on an elderly patient. Gerodontology. 2009. June 22 [DOI] [PubMed]
  • 13:Mavrogiannis M, Ellis JS, Seymour RA, Thomason JM. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth. J Clin Periodontol. 2006. September;33(9):677-82 Epub 2006. July 20 [DOI] [PubMed] [Google Scholar]
  • 14:Vorkas CK, Gopinathan MK, Singh A, Devinsky O, Lin LM, Rosenberg PA.: Epilepsy and dental procedures. A review. N Y State Dent J. 2008. March;74(2):39-43 [PubMed] [Google Scholar]
  • 15:Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA.: The management of drug-induced gingival overgrowth. J Clin Periodontol. 2006. June;33(6):434-9 [DOI] [PubMed] [Google Scholar]
  • 16:Fornaini C, Rocca JP, Bertrand MF, Merigo E, Nammour S, Vescovi P.: Nd:YAG and diode laser in the surgical management of soft tissues related to orthodontic treatment. Photomed Laser Surg. 2007. October;25(5):381-92 [DOI] [PubMed] [Google Scholar]
  • 17:Haytac CM, Ustun Y, Essen E, Ozcelik O.: Combined treatment approach of gingivectomy and CO2 laser for cyclosporine-induced gingival overgrowth. Quintessence Int. 2007. January;38(1):e54-9 [PubMed] [Google Scholar]
  • 18:Tracey R.: Soft-tissue surgery: use of the Er,Cr:YSGG laser. Dent Today. 2008. February;27(2):156-9 [PubMed] [Google Scholar]
  • 19:Gama SK, De Araújo TM, Pozza DH, Pinheiro AL.: Use of the CO2 laser on orthodontic patients suffering from gingival hyperplasia. Photomed Laser Surg. 2007. June;25(3):214-9 [DOI] [PubMed] [Google Scholar]

Articles from Laser Therapy are provided here courtesy of Japan Medical Laser Laboratory

RESOURCES